mogamulizumab

Ligand id: 6477

Name: mogamulizumab

No information available.
Summary of Clinical Use
Currently approved only in Japan, for the treatment of relapsed or refractory adult T-cell leukemia/lymphoma.
Mechanism Of Action and Pharmacodynamic Effects
Targets CCR4.